Estados financieros detallados de Puma Biotechnology, Inc. (PBYI): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Puma Biotechnology, Inc. registró ingresos de $228.4M en el último ejercicio fiscal, con un CAGR de 5 años del 0.3%.
Márgenes de los últimos 12 meses: margen bruto 74.8%, margen operativo 13.2%, margen neto 11.6%.
Al precio actual de $9.39, PBYI cotiza a un P/E de 16.72 y un ROE del 20.85%. La capitalización bursátil es de $478M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | $27.7M | $251.0M | $272.3M | $225.1M | $253.2M | $228.0M | $235.6M | $230.5M | $228.4M |
| Coste de Ventas | $1.1M | $5.6M | $34.6M | $36.8M | $39.4M | $63.7M | $55.1M | $62.7M | $64.4M | $58.2M |
| Beneficio Bruto | -$1.1M | $22.1M | $216.4M | $235.4M | $185.7M | $189.5M | $172.9M | $173.0M | $166.1M | $170.2M |
| I+D | $222.8M | $207.8M | $164.9M | $132.9M | $97.7M | $71.9M | $52.2M | $50.4M | $54.9M | $62.1M |
| Generales y Administrativos | $53.8M | $106.7M | $146.2M | $141.6M | $118.5M | $116.3M | $90.0M | $89.3M | $80.2M | $71.2M |
| Gastos Operativos | $276.6M | $314.5M | $311.1M | $311.0M | $216.1M | $188.2M | $149.2M | $140.3M | $135.1M | $132.9M |
| Beneficio Operativo | -$276.6M | -$292.4M | -$94.7M | -$75.6M | -$30.4M | $1.3M | $23.7M | $32.6M | $31.0M | $37.3M |
| EBITDA | -$275.4M | -$288.4M | -$95.2M | -$52.4M | -$35.7M | -$4.7M | $21.9M | $47.5M | $48.1M | $53.3M |
| Gastos por Intereses | $958000 | $720000 | $11.0M | $15.0M | $14.0M | $12.8M | $11.6M | $13.3M | $12.5M | $6.6M |
| Beneficio Antes de Impuestos | -$276.0M | -$292.0M | -$113.6M | -$75.5M | -$59.8M | -$28.8M | $457000 | $22.7M | $24.1M | $35.8M |
| Impuestos | -$2.1M | -$2.2M | -$7.9M | $53000 | $207000 | $324000 | $455000 | $1.1M | -$6.2M | $4.7M |
| Beneficio Neto | -$276.0M | -$292.0M | -$113.6M | -$75.6M | -$60.0M | -$29.1M | $2000 | $21.6M | $30.3M | $31.1M |
| BPA | $-8.29 | $-7.86 | $-2.99 | $-2.13 | $-1.52 | $-0.72 | $0.02 | $0.46 | $0.62 | $0.62 |
| BPA Diluido | $-8.29 | $-7.86 | $-2.99 | $-2.13 | $-1.52 | $-0.72 | $0.02 | $0.45 | $0.62 | $0.61 |
| Acciones en Circulación (Diluidas) | $33.3M | $37.2M | $37.9M | $38.8M | $39.6M | $40.6M | $44.9M | $47.6M | $49.1M | $50.7M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $54.5M | $75.5M | $44.8M | $56.5M |
| Beneficio Bruto | $42.3M | $52.3M | $34.4M | $44.0M |
| Beneficio Operativo | $9.6M | $17.1M | -$3.8M | $7.6M |
| EBITDA | $13.5M | $20.9M | -$196000 | $13.5M |
| Beneficio Neto | $8.8M | $13.4M | -$3.8M | $8.2M |
| BPA | $0.18 | $0.27 | $-0.07 | $0.16 |
| BPA Diluido | $0.17 | $0.26 | $-0.07 | $0.16 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $194.5M | $81.7M | $108.4M | $60.0M | $85.3M | $63.1M | $76.2M | $84.6M | $69.2M | $29.6M |
| Inversiones a Corto | 0 | 0 | 0 | $51.6M | $8.1M | $19.0M | $4.9M | $11.4M | $31.7M | $67.9M |
| Cuentas por Cobrar | 0 | $9.7M | $21.9M | $28.9M | $25.5M | $32.5M | $42.3M | $48.5M | $32.0M | $53.7M |
| Inventario | 0 | $2.0M | $2.6M | $3.2M | $3.5M | $7.1M | $4.5M | $7.1M | $8.7M | $5.5M |
| Activos Corrientes | $236.5M | $106.4M | $203.0M | $166.3M | $146.1M | $140.0M | $134.3M | $156.2M | $147.7M | $162.7M |
| Inmovilizado Material | $5.2M | $4.5M | $4.0M | $21.8M | $18.9M | $15.8M | $12.5M | $8.6M | $5.1M | $5.6M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | $48.4M | $44.4M | $40.5M | $74.1M | $66.1M | $70.6M | $60.9M | $51.1M | $41.4M |
| Activos Totales | $252.8M | $165.5M | $259.1M | $234.9M | $244.2M | $226.6M | $222.1M | $230.5M | $213.3M | $216.3M |
| Cuentas por Pagar | $20.0M | $27.7M | $20.7M | $19.2M | $12.1M | $11.2M | $6.4M | $6.9M | $5.5M | $5.1M |
| Deuda a Corto | 0 | 0 | 0 | 0 | $14.3M | 0 | 0 | $34.0M | $45.3M | $22.5M |
| Pasivos Corrientes | $37.5M | $58.3M | $67.1M | $90.8M | $114.3M | $109.6M | $77.5M | $99.4M | $96.1M | $81.3M |
| Deuda a Largo | 0 | $48.5M | $151.9M | $95.0M | $84.0M | $97.1M | $98.3M | $65.7M | $21.7M | 0 |
| Pasivos Totales | $43.0M | $112.2M | $224.8M | $217.4M | $250.2M | $229.0M | $200.5M | $177.1M | $121.2M | $86.0M |
| Reservas | -$796.5M | -$1.09B | -$1.20B | -$1.28B | -$1.34B | -$1.37B | -$1.37B | -$1.35B | -$1.31B | -$1.28B |
| Patrimonio Neto | $209.8M | $53.3M | $34.3M | $17.5M | -$6.0M | -$2.4M | $21.6M | $53.4M | $92.1M | $130.3M |
| Deuda Total | 0 | $48.5M | $151.9M | $120.2M | $121.0M | $116.6M | $114.3M | $111.5M | $74.1M | $28.5M |
| Deuda Neta | -$194.5M | -$33.2M | $43.5M | $8.6M | $27.6M | $34.5M | $33.2M | $15.6M | -$26.9M | -$69.0M |
| Capital Circulante | $199.0M | $48.1M | $135.9M | $75.5M | $31.9M | $30.4M | $56.8M | $56.8M | $51.5M | $81.4M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $53.5M | $29.6M | $36.2M | $36.5M |
| Activos Totales | $202.9M | $216.3M | $192.7M | $192.7M |
| Pasivos Totales | $87.6M | $86.0M | $64.3M | $54.2M |
| Patrimonio Neto | $115.3M | $130.3M | $128.4M | $138.5M |
| Deuda Total | $41.1M | $28.5M | $16.0M | $4.8M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$276.0M | -$292.0M | -$113.6M | -$75.6M | -$60.0M | -$29.1M | $2000 | $21.6M | $30.3M | $31.1M |
| Amortizaciones | $1.1M | $2.8M | $7.4M | $8.1M | $10.0M | $11.3M | $9.8M | $11.5M | $11.5M | $10.9M |
| Compensación en Acciones | $117.3M | $108.7M | $86.9M | $57.3M | $36.6M | $32.6M | $11.8M | $10.2M | $8.2M | $6.9M |
| Cambio en Capital Circulante | $12.5M | $7.9M | -$5.1M | $23.3M | $13.2M | -$1.3M | -$44.5M | -$17.9M | -$3.5M | -$10.1M |
| Flujo de Caja Operativo | -$141.7M | -$172.5M | -$24.1M | $22.4M | $800000 | $20.6M | -$15.8M | $27.0M | $38.9M | $41.8M |
| Inversiones (CapEx) | -$7.3M | -$50.4M | -$609000 | -$306000 | -$20.0M | 0 | -$7.0M | -$12.6M | -$56000 | -$71000 |
| Adquisiciones | $15000 | $36000 | $193000 | 0 | $20.0M | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$149.0M | -$222.9M | -$24.7M | $22.1M | -$19.2M | $20.6M | -$22.8M | $14.4M | $38.9M | $41.7M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | $9.7M | $14.4M | $15.4M | $1.6M |
| Inversiones (CapEx) | -$26000 | $36000 | 0 | 0 |
| Flujo de Caja Libre | $9.7M | $14.5M | $15.4M | $1.6M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.7M | $1.6M | $1.9M | $2.0M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | +806.1% | +8.5% | -17.3% | +12.5% | -9.9% | +3.3% | -2.2% | -0.9% |
| Crecimiento Beneficio Neto (anual) | | -5.8% | +61.1% | +33.5% | +20.6% | +51.5% | +100.0% | +1079450.0% | +40.2% | +2.8% |
| Crecimiento BPA (anual) | | +5.2% | +62.0% | +28.8% | +28.6% | +52.6% | +102.8% | +2154.9% | +34.8% | +0.0% |
| Cambio en Acciones (anual) | | +11.6% | +2.1% | +2.2% | +2.1% | +2.7% | +10.6% | +5.8% | +3.3% | +3.2% |
| Crecimiento FCF (anual) | | -49.6% | +88.9% | +189.3% | -187.2% | +207.3% | -210.5% | +162.9% | +170.5% | +7.4% |
| Margen Bruto | | 79.8% | 86.2% | 86.5% | 82.5% | 74.8% | 75.8% | 73.4% | 72.1% | 74.5% |
| Margen Operativo | | -1055.6% | -37.7% | -27.8% | -13.5% | 0.5% | 10.4% | 13.9% | 13.4% | 16.3% |
| Margen EBITDA | | -1041.2% | -37.9% | -19.3% | -15.9% | -1.9% | 9.6% | 20.2% | 20.9% | 23.4% |
| Margen Neto | | -1054.2% | -45.3% | -27.8% | -26.7% | -11.5% | 0.0% | 9.2% | 13.1% | 13.6% |
| Margen FCF | | -804.8% | -9.8% | 8.1% | -8.5% | 8.2% | -10.0% | 6.1% | 16.9% | 18.3% |
| Tasa Impositiva Efectiva | 0.8% | 0.8% | 7.0% | -0.1% | -0.3% | -1.1% | 99.6% | 4.8% | -25.6% | 13.1% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-4.47 | $-6.00 | $-0.65 | $0.57 | $-0.49 | $0.51 | $-0.51 | $0.30 | $0.79 | $0.82 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $33.3M | $37.2M | $37.9M | $38.8M | $39.6M | $40.6M | $44.7M | $47.1M | $48.6M | $50.0M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 20.85% |
| Rentabilidad sobre capital invertido | 18.20% |
| Rentabilidad sobre activos | 13.86% |
| Margen bruto | 74.83% |
| Margen operativo | 13.16% |
| Margen neto | 11.55% |
Salud financiera
| Deuda / Patrimonio | 0.03 |
| Ratio corriente | 2.91 |
| Piotroski F-Score | 7 |
| Altman Z-Score | -4.16 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -3.70 | -12.58 | -6.81 | -4.11 | -6.75 | -4.22 | 207.35 | 9.41 | 4.92 | 9.60 |
| P/VC | 4.87 | 68.93 | 22.51 | 19.43 | -68.23 | -50.51 | 8.75 | 3.82 | 1.61 | 2.28 |
| P/V | 0.00 | 132.64 | 3.08 | 1.25 | 1.80 | 0.49 | 0.83 | 0.87 | 0.64 | 1.30 |
| Margen Bruto | 0.0% | 79.8% | 86.2% | 86.5% | 82.5% | 74.8% | 75.8% | 73.4% | 72.1% | 74.5% |
| Margen Operativo | 0.0% | -1055.6% | -37.7% | -27.8% | -13.5% | 0.5% | 10.4% | 13.9% | 13.4% | 16.3% |
| Margen Neto | 0.0% | -1054.2% | -45.3% | -27.8% | -26.7% | -11.5% | 0.0% | 9.2% | 13.1% | 13.6% |